RESUMEN
UNLABELLED: 3-Phosphoglycerate dehydrogenase (3-PGDH) deficiency is considered to be a rare cause of congenital microcephaly, infantile onset of intractable seizures and severe psychomotor retardation. Here, we report for the first time a very mild form of genetically confirmed 3-PGDH deficiency in two siblings with juvenile onset of absence seizures and mild developmental delay. Amino acid analysis showed serine values in CSF and plasma identical to what is observed in the severe infantile form. Both patients responded favourably to relatively low dosages of serine supplementation with cessation of seizures, normalisation of their EEG abnormalities and improvement of well-being and behaviour. These cases illustrate that 3-PGDH deficiency can present with mild symptoms and should be considered as a treatable disorder in the differential diagnosis of mild developmental delay and seizures. SYNOPSIS: we present a novel mild phenotype in patients with 3-PGDH deficiency.
Asunto(s)
Encefalopatías Metabólicas Innatas/diagnóstico , Encefalopatías Metabólicas Innatas/etiología , Fosfoglicerato-Deshidrogenasa/deficiencia , Adolescente , Encefalopatías Metabólicas Innatas/complicaciones , Diagnóstico Diferencial , Femenino , Humanos , Discapacidad Intelectual/complicaciones , Discapacidad Intelectual/diagnóstico , Masculino , Microcefalia/complicaciones , Microcefalia/diagnóstico , Microcefalia/etiología , Convulsiones/complicaciones , Convulsiones/diagnóstico , Convulsiones/etiología , HermanosRESUMEN
Three-phosphoglycerate dehydrogenase (3-PGDH) deficiency is a rare recessive inborn error in the biosynthesis of the amino acid L-serine characterized clinically by congenital microcephaly, psychomotor retardation, and intractable seizures. The biochemical abnormalities associated with this disorder are low concentrations of L-serine, D-serine, and glycine in cerebrospinal fluid (CSF). Only two missense mutations (p.V425M and p.V490M) have been identified in PHGDH, the gene encoding 3-PGDH, but it is currently unclear how these mutations in the carboxy-terminal regulatory domain of the protein affect enzyme function. We now describe five novel mutations in five patients with 3-PGDH deficiency; one frameshift mutation (p.G238fsX), and four missense mutations (p.R135W, p.V261M, p.A373T, and p.G377S). The missense mutations were located in the nucleotide binding and regulatory domains of 3-PGDH and did not affect steady-state expression, protein stability, and protein degradation rates. Patients' fibroblasts displayed a significant, but incomplete, reduction in maximal enzyme activities associated with all missense mutations. In transient overexpression studies in HEK293T cells, the p.A373T, p.V425M, and p.V490M mutations resulted in almost undetectable enzyme activities. Molecular modeling of the p.R135W and p.V261M mutations onto the partial crystal structure of 3-PGDH predicted that these mutations affect substrate and cofactor binding. This prediction was confirmed by the results of kinetic measurements in fibroblasts and transiently transfected HEK293T cells, which revealed a markedly decreased V(max) and an increase in K(m) values, respectively. Taken together, these data suggest that missense mutations associated with 3-PGDH deficiency either primarily affect substrate binding or result in very low residual enzymatic activity.
Asunto(s)
Mutación/genética , Fosfoglicerato-Deshidrogenasa/genética , Fosfoglicerato-Deshidrogenasa/metabolismo , Secuencia de Bases , Línea Celular , Cristalografía por Rayos X , Análisis Mutacional de ADN , Femenino , Fibroblastos/enzimología , Fibroblastos/patología , Humanos , Cinética , Masculino , Datos de Secuencia Molecular , Mutación Missense/genética , Fosfoglicerato-Deshidrogenasa/química , Procesamiento Proteico-Postraduccional , Estructura Secundaria de Proteína , TransfecciónRESUMEN
The trace metal copper is essential for a variety of biological processes, but extremely toxic when present in excessive amounts. Therefore, concentrations of this metal in the body are kept under tight control. Central regulators of cellular copper metabolism are the copper-transporting P-type ATPases ATP7A and ATP7B. Mutations in ATP7A or ATP7B disrupt the homeostatic copper balance, resulting in copper deficiency (Menkes disease) or copper overload (Wilson disease), respectively. ATP7A and ATP7B exert their functions in copper transport through a variety of interdependent mechanisms and regulatory events, including their catalytic ATPase activity, copper-induced trafficking, post-translational modifications and protein-protein interactions. This paper reviews the extensive efforts that have been undertaken over the past few years to dissect and characterise these mechanisms, and how these are affected in Menkes and Wilson disease. As both disorders are characterised by an extensive clinical heterogeneity, we will discus how the underlying genetic defects correlate with the molecular functions of ATP7A and ATP7B and with the clinical expression of these disorders.
Asunto(s)
Adenosina Trifosfatasas/genética , Proteínas de Transporte de Catión/genética , Degeneración Hepatolenticular/genética , Síndrome del Pelo Ensortijado/genética , Adenosina Trifosfatasas/química , Adenosina Trifosfatasas/fisiología , Adenosina Trifosfato/metabolismo , Animales , Proteínas de Transporte de Catión/química , Proteínas de Transporte de Catión/fisiología , Cobre/metabolismo , ATPasas Transportadoras de Cobre , Modelos Animales de Enfermedad , Femenino , Genotipo , Degeneración Hepatolenticular/metabolismo , Humanos , Masculino , Síndrome del Pelo Ensortijado/metabolismo , Ratones , Ratones Mutantes , Mutación Missense , Fenotipo , Mapeo de Interacción de Proteínas , Estructura Terciaria de Proteína , Ratas , Ratas Endogámicas LEC , Relación Estructura-Actividad , Pez CebraRESUMEN
Bile acids and bile salts have essential functions in the liver and in the small intestine. Their synthesis in the liver provides a metabolic pathway for the catabolism of cholesterol and their detergent properties promote the solubilisation of essential nutrients and vitamins in the small intestine. Inherited conditions that prevent the synthesis of bile acids or their excretion cause cholestasis, or impaired bile flow. These disorders generally lead to severe human liver disease, underscoring the essential role of bile acids in metabolism. Recent advances in the elucidation of gene defects underlying familial cholestasis syndromes has greatly increased knowledge about the process of bile flow. The expression of key proteins involved in bile flow is tightly regulated by transcription factors of the nuclear hormone receptor family, which function as sensors of bile acids and cholesterol. Here we review the genetics of familial cholestasis disorders, the functions of the affected genes in bile flow, and their regulation by bile acids and cholesterol.
Asunto(s)
Colestasis Intrahepática/genética , Transportadoras de Casetes de Unión a ATP/genética , Bilis/metabolismo , Ácidos y Sales Biliares/biosíntesis , Ácidos y Sales Biliares/química , Ácidos y Sales Biliares/metabolismo , Humanos , Proteínas de la Membrana/genética , Mutación , Síndrome , Proteína de la Zonula Occludens-2RESUMEN
3-phosphoglycerate-dehydrogenase (3-PGDH) deficiency is an L-serine biosynthesis disorder, characterised by congenital microcephaly, severe psychomotor retardation, and intractable seizures. We report prenatal diagnosis of an affected fetus by DNA mutation analysis. Ultrasound assessment showed a reduction in fetal head circumference from the 75th percentile at 20 weeks' gestation to the 29th percentile at 26 weeks. L-serine was then given to the mother, which resulted in an enlarged fetal head circumference to the 76th percentile at 31 weeks. At birth, the girl's head circumference was normal, and at 48 months' follow-up, her psychomotor development has been unremarkable. 3-PGDH deficiency is an inborn metabolic error that can be successfully treated antenatally.
Asunto(s)
Errores Innatos del Metabolismo de los Aminoácidos/tratamiento farmacológico , Deshidrogenasas de Carbohidratos/deficiencia , Terapias Fetales , Diagnóstico Prenatal , Serina/administración & dosificación , Encéfalo/embriología , Muestra de la Vellosidad Coriónica , Femenino , Humanos , Recién Nacido , Discapacidad Intelectual/prevención & control , Microcefalia/prevención & control , Fosfoglicerato-Deshidrogenasa , Embarazo , Serina/sangre , Serina/metabolismo , Ultrasonografía PrenatalRESUMEN
Wilson disease is an autosomal recessive disorder of copper metabolism. The gene defective in Wilson disease encodes a copper transporting P-type ATPase expressed in the liver. The disturbed export of copper into bile results in accumulation of copper in liver and secondarily in other organs such as the brain. These patients generally present with either hepatic or neurological symptoms.